AXA/2025/FY/Earnings presentation: Difference between revisions
Content deleted Content added
PlumBot: publish from draft |
PlumBot: publish from draft |
||
Line 24:
=== Important legal information and cautionary statements concerning forward-looking statements and the use of non-GAAP financial measures ===
* Certain statements are forward-looking, including predictions of future events, trends, plans, expectations, or objectives
* Forward-looking statements are identified by words like 'expects', 'anticipates', 'may', 'plan,' 'target', 'would', and 'could' <sup>p. 2</sup>.
* Statements regarding expected '''underlying earnings per share (UEPS) growth''' for 2026 are forward-looking, providing one-off guidance for the last year of the Group's current strategic plan <sup>p. 2</sup>.
* These statements are based on Management's current views and intentions and are subject to change <sup>p. 2</sup>.
* Undue reliance should not be placed on forward-looking statements due to known and unknown risks and uncertainties
* Factors could cause AXA's actual results to differ materially from those expressed or implied <sup>p. 2</sup>.
* Each forward-looking statement speaks only at the date of this presentation <sup>p. 2</sup>.
* Refer to Part 5 'Risk Factors and Risk Management' of AXA's Universal Registration Document for the year ended December 31, 2024 (the '2024 Universal Registration Document') for a description of important factors, risks, and uncertainties <sup>p. 2</sup>.
* AXA disclaims any obligation to publicly update or revise any forward-looking statements, except as required by applicable laws and regulations <sup>p. 2</sup>.
* This presentation refers to certain non-GAAP financial measures, or alternative performance measures ('APMs'), used by Management for analyzing operating trends, financial performance, and
* These non-GAAP financial measures generally have no standardized meaning and may not be comparable to similarly labeled measures used by other companies <sup>p. 2</sup>.
*
* '''Underlying earnings''', '''UEPS''' ('underlying earnings per share'), '''underlying return on equity''', '''combined ratio''', and '''debt gearing''' are APMs as defined in ESMA's guidelines and
* AXA provides a reconciliation of such APMs to the most closely related line item, subtotal, or total in the financial statements of the corresponding period (and/or their calculation methodology) in its Activity Report as of December 31, 2025 ('AXA's 2025 Activity Report'), under the heading 'Use of non-GAAP and alternative performance measures' <sup>p. 2</sup>.
* For further information on non-GAAP financial measures, see the Glossary in AXA's 2025 Activity Report <sup>p. 2</sup>.
Line 42 ⟶ 44:
=== Table of contents ===
* '''1. FY25 Highlights''': presented by Thomas Buberl, Group CEO, starting on
* '''2. FY25 Business Performance''': presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology, starting on
* '''3. FY25 Financial Performance''': presented by Alban de Mailly Nesle, Group CFO, starting on
== FY25 Highlights ==
*
=== Full Year 2025 | Excellent performance ===
* '''Revenues''' +6% vs. FY24 <sup>p. 5</sup>
* '''ROE''' 16% in FY25 <sup>p. 5</sup>
* '''Underlying EPS''' +8% vs. FY24 <sup>p. 5</sup>
* '''
* Delivering value for shareholders with +8% '''
** '''Dividend''' proposed by AXA's Board of Directors on February 25, 2026, subject to approval by Shareholders' Annual General Meeting on April 30, 2026 <sup>p. 5</sup>.
**
* Confident to deliver '''underlying EPS growth''' at the upper end of 6%-8% target range for 2026 <sup>p. 5</sup>
=== Executing the plan on growth, margin and efficiency ===
Line 66 ⟶ 67:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
Line 76 ⟶ 77:
|}
</div>
* Underlying earnings +6% <sup>p. 6</sup>
*
* Consistent earnings growth while enhancing reserve prudence <sup>p. 6</sup>
* Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX <sup>p. 6</sup>
=== Diversified franchise, well positioned in an attractive industry ===
Line 110 ⟶ 108:
|}
</div>
* Secular trends fueling demand across businesses <sup>p. 7</sup>
* Protection gaps and emerging corporate risks (relevant for SME & Mid-market and Large & Specialty segments) <sup>p. 7</sup>
* Our right to win <sup>p. 7</sup>
*
=== Laying the foundation for the next plan ===
Line 130 ⟶ 126:
== FY25 Business Performance ==
* Guillaume Borie <sup>p. 9</sup>
* Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 9</sup>
=== Strong delivery across our businesses ===
Line 141 ⟶ 134:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | GWP
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" | Underlying earnings
! class="col-s" style="text-align:right" | Underlying earnings change
! class="col-s" style="text-align:right" | % of total GWP
|-
| style="text-align:left" | France
| style="text-align:right" | 31
| style="text-align:right" | +
| style="text-align:right" | 2.2
| style="text-align:right" | +7%
| style="text-align:right" | 27%
|-
| style="text-align:left" | Europe
| style="text-align:right" | 43
| style="text-align:right" | +
| style="text-align:right" | 3.5
| style="text-align:right" | +9%
| style="text-align:right" | 38%
|-
| style="text-align:left" | AXA XL
| style="text-align:right" | 19
| style="text-align:right" | +
| style="text-align:right" | 1.9
| style="text-align:right" | +9%
| style="text-align:right" | 17%
|-
| style="text-align:left" | Asia, Africa & EME-LATAM
| style="text-align:right" | 20
| style="text-align:right" | +
| style="text-align:right" | 1.5
| style="text-align:right" | +6%
| style="text-align:right" | 18%
|}
</div>
* Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX
* ¹ FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers
=== P&C | Strong margins, confidence in sustaining growth ===
Line 184 ⟶ 178:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ GWP split
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Share
Line 198 ⟶ 192:
|}
</div>
* Underlying earnings +9%
* Includes AXA XL Re premiums of EUR 2.6bn
* '''2025 Strategic Focus'''
** '''Retail and SME & Mid-market''': Growing volumes while expanding margins
** '''AXA XL''' (Large & Specialty): Profitable growth with stable margins
*
** '''Retail and SME & Mid-market''': Investing to improve customer retention & expanding distribution footprint
** '''AXA XL''' (Large & Specialty): Capitalizing on attractive growth opportunities and continued cycle management
*
** Continued progress on efficiency
** Higher investment income
** Data & AI to further enhance customer experience & technical excellence
=== L&H | Good momentum, well positioned to capture growth opportunities ===
Line 215 ⟶ 209:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ GWP split
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Share
Line 226 ⟶ 220:
|}
</div>
* Underlying earnings +7%
*
** '''Long-term business''': Accelerating net flows in Savings at attractive margins
** '''Short-term business''': Growing technical results while absorbing Mexico VAT impact
*
** '''Long-term business''': Capturing savings & retirement opportunity, sourcing best asset management products for our customers
** '''Short-term business''': Capitalizing on demand for health & protection while further improving our margins
*
** Focus on cost reduction
** Increasing penetration of Protection riders in Savings offerings
Line 240 ⟶ 234:
== FY25 Financial Performance ==
*
* Alban de Mailly Nesle, Group CFO <sup>p. 13</sup>
=== P&C | Continued disciplined growth ===
Line 249 ⟶ 242:
{| class="wikitable fintable"
|+ GWP & other revenues by line, FY24 vs FY25 <sup>p. 14</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
Line 270 ⟶ 263:
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Change at constant scope and FX <sup>p. 14</sup>
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Change
! class="col-s" style="text-align:right" | Pricing
! class="col-s" style="text-align:right" | Volume
|-
| style="text-align:left" | Commercial lines
| style="text-align:right" | +4%
| style="text-align:right" | +2%
| style="text-align:right" | +2%
|-
| style="text-align:left" | AXA XL Reinsurance
| style="text-align:right" | +8%
| style="text-align:right" | +0.3%
| style="text-align:right" | +7%
|-
| style="text-align:left" | Retail lines
| style="text-align:right" | +7%
| style="text-align:right" | +5%
| style="text-align:right" | +2%
|}
</div>
* Continued pricing momentum and volume growth in Mid-market and SME
* Growing in lines of business with attractive margins while remaining focused on retention at AXA XL Insurance
* Growth supported by alternative capital
* Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25)
* (table) '''Change at constant scope and FX''' <sup>p. 14</sup>
=== P&C | Delivering further margin expansion while enhancing reserve prudence ===
Line 283 ⟶ 298:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Combined ratio
! style="text-align:left" | —
! class="col-s" style="text-align:right" | FY24
Line 313 ⟶ 328:
|}
</div>
* Better undiscounted current year loss ratio excluding Nat Cat from:
** Margin expansion in Commercial lines SME & mid-market business and Personal lines reflecting favorable pricing environment
** Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management
* Improvement in expense ratio reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology
* Nat Cat charges below normalized load
* Lower reliance on prior year reserve development
* Taking advantage of a good year to enhance reserve prudence
=== P&C | Earnings growth from higher underwriting and financial result ===
Line 354 ⟶ 369:
|}
</div>
* Underlying Earnings +9% (
* Better underwriting result from strong volume growth and improved all-year combined ratio while enhancing reserve prudence
* Increase in investment income reflecting higher volumes and better reinvestment yields on fixed income assets
* Higher unwind of discount of claims reserves, in line with guidance
* Unfavorable forex impact notably due to USD depreciation vs. EUR
=== Life & Health | Strong growth in premiums, positive net flows ===
Line 364 ⟶ 379:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | '''Life GWP & Other Revenues'''
| style="text-align:right" | 34.5
| style="text-align:right" | 37.5
| style="text-align:right" | +9%
|-
| style="text-align:left" | Protection
Line 390 ⟶ 410:
| style="text-align:right" | -7%
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Individual
Line 414 ⟶ 424:
| style="text-align:right" | 7.9
| style="text-align:right" | +4%
|}
</div>
Line 445 ⟶ 450:
</div>
* Net flows: EUR +5.4bn vs. EUR +1.5bn in FY24
* Employee Benefits (short-term and long-term) FY25: EUR 12.9bn (+4% vs. FY24)
=== Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting ===
<div style="overflow-x:auto">
Line 459 ⟶ 462:
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | '''PVEP'''
| style="text-align:right" | 50.9
| style="text-align:right" | 49.4
| style="text-align:right" | -2%
|-
| style="text-align:left" | Protection & Health
Line 479 ⟶ 487:
| style="text-align:right" | 1.7
| style="text-align:right" | -10%
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ NB CSM
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | NB CSM (pre-tax)
| style="text-align:right" | 2.2
| style="text-align:right" | 2.2
|-
| style="text-align:left" | NBV (post-tax)
| style="text-align:right" | 2.3
| style="text-align:right" | 2.2
Line 522 ⟶ 510:
|}
</div>
* PVEP was impacted by higher interest rates on discounting despite strong growth in Life volumes
* NB CSM was driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits
* NBV was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France
* (bar) '''NB CSM''' (pre-tax) +3% (constant scope and FX) <sup>p. 18</sup>
=== Life & Health | Growth in new business driving Normalized CSM growth ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Contractual Service Margin rollforward
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Contractual Service Margin
Line 559 ⟶ 550:
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Life
| style="text-align:right" | 25.8
| style="text-align:right" | 25.4
|-
| style="text-align:left" | Health
| style="text-align:right" | 7.7
| style="text-align:right" | 7.6
|}
</div>
* Normalized CSM up by +2% (constant scope and FX), with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates
* Economic variance reflecting government spreads tightening and positive equity market returns
* Operating variance driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland
* FX impact mainly from JPY and HKD depreciation
=== Life & Health | Strong momentum in both short-term and long-term business ===
Line 569 ⟶ 576:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" | Underlying
|-
| style="text-align:left" | FY24
Line 593 ⟶ 600:
</div>
* '''Underlying Earnings''' +7% (
* Strong '''
* Higher '''
* '''Underlying Earnings
** '''
** '''Health''': FY24 EUR 0.7bn, FY25 EUR 0.8bn (+17% vs. FY24) <sup>p. 20</sup>
* '''Short-term technical margin''': EUR 479m <sup>p. 20</sup>
* '''Long-term result incl. CSM release''': EUR 2,804m <sup>p. 20</sup>
Line 607 ⟶ 615:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings and
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
Line 614 ⟶ 622:
|-
| style="text-align:left" | '''Underlying earnings'''
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | +6%
|-
| style="text-align:left" | Property & Casualty
| style="text-align:right" |
| style="text-align:right" | 5.9
| style="text-align:right" | +9%
|-
| style="text-align:left" | Life & Health
| style="text-align:right" |
| style="text-align:right" | 3.5
| style="text-align:right" | +7%
|-
| style="text-align:left" | Asset Management
| style="text-align:right" |
| style="text-align:right" | 0.2
| style="text-align:right" | -57%
|-
| style="text-align:left" | Holdings & other
| style="text-align:right" | -1.2
| style="text-align:right" |
| style="text-align:right" | -
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | +6%
|-
| style="text-align:left" | '''Net income'''
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | +26%
|-
| style="text-align:left" | Non-financial flows
| style="text-align:right" | -0.5
| style="text-align:right" |
| style="text-align:right" | —
|-
| style="text-align:left; padding-left:1.5em" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | —
|-
| style="text-align:left" | Financial flows (incl. RCG)
| style="text-align:right" |
| style="text-align:right" | -0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Net income total
| style="text-align:right" | 7.9
| style="text-align:right" | 9.8
| style="text-align:right" | +26%
|}
</div>
Line 663 ⟶ 681:
{| class="wikitable fintable"
|+ Underlying earnings per share walk, FY24 to FY25 <sup>p. 21</sup>
! style="text-align:left" | EUR
! class="col-s" style="text-align:right" | Underlying earnings per share
|-
Line 683 ⟶ 701:
</div>
* '''Underlying earnings''':
* '''
* '''Net income''': Higher net income mainly reflecting higher underlying earnings and the gain from the sale of AXA IM <sup>p. 21</sup>
* '''
*
*
* (bar) '''Underlying earnings per share''': EUR 3.59 (FY24) → EUR 3.86 (FY25) (+8%) <sup>p. 21</sup>
* including -1% from temporary earnings dilution from AXA IM sale due to the timing of anti-dilutive share buyback <sup>p. 21</sup>
=== Shareholders' Equity ===
Line 729 ⟶ 749:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Shareholders' equity
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24 to FY25
Line 748 ⟶ 768:
| style="text-align:left" | Dividend
| style="text-align:right" | -4.6
| style="text-align:right" |
|-
| style="text-align:left" | Annual share buyback
| style="text-align:right" | -1.2
| style="text-align:right" |
|-
| style="text-align:left" | Anti-dilutive share buyback following the sale of AXA IM
Line 775 ⟶ 795:
|}
</div>
* 1. Shareholders' equity Group share <sup>p. 22</sup>
* '''Shareholders' equity reconciliation''' (in Euro billion) <sup>p. 22</sup>
=== Higher organic cash remittance and robust cash position at Holding ===
Line 780 ⟶ 803:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Net Cash
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Net Cash Remittance
| style="text-align:right" | 7.7
| style="text-align:right" | 7.5
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" | 82%
|-
| style="text-align:left" |
| style="text-align:right" | 4.0
| style="text-align:right" | 5.6
|}
</div>
*
* Net cash remittance from subsidiaries: +EUR 7.5bn
* Dividend: -EUR 4.6bn
* Annual share buyback: -EUR 1.2bn
* Anti-dilutive share buyback following the sale of AXA IM: -EUR 3.5bn
* Holding costs and interest expenses: -EUR 1.3bn
* Change in net debt: +EUR 1.6bn
* M&A and other: +EUR 3.1bn
* 1. Based on ordinary cash remittance of Euro 7.1 billion in FY24 and Euro 7.5 billion in FY25
* 2. EUR 0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe
=== Solvency II at 224% ===
Line 838 ⟶ 837:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Solvency II walk
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | Eligible Own Funds (EOF)
! class="col-s" style="text-align:right" | Solvency Capital Requirement (SCR)
! class="col-s" style="text-align:right" | Solvency II ratio (pts)
|-
Line 888 ⟶ 887:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Key sensitivities on Solvency II
! style="text-align:left" | Sensitivity
! class="col-s" style="text-align:right" | Impact (pts)
Line 924 ⟶ 923:
</div>
* Dividend & annual share buyback: Foreseeable dividends: EUR 4.8bn; Provision for annual Share buyback for 2026: EUR -1.25bn
*
* 2. Sensitivity to credit rating migration assumes 20% of corporate bonds (including private debt) held are downgraded by one full letter (3 notches)
=== Solvency II -impact of the end of grandfathering period and Solvency II revision ===
Line 932 ⟶ 931:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Solvency II ratio
! style="text-align:left" | Item
! class="col-
|-
| style="text-align:left" | Ratio as of 31/12/2025
| style="text-align:right" | 224%
|-
| style="text-align:left" | Impact of the end of grandfathering period on January 1, 2026
| style="text-align:right" | -
|-
| style="text-align:left" | Impact of Solvency II revision to come into effect in 1Q27
| style="text-align:right" | +
|}
</div>
*
* No change expected in organic capital generation
* Additional capital flexibility
*
=== Thomas Buberl, Group CEO conclusion ===
* Conclusion
* Thomas Buberl, Group CEO <sup>p. 26</sup>
=== Conclusion ===
Line 968 ⟶ 965:
=== February 26, 2026 Q&A Full Year 2025 earnings ===
* Q&A
*
* February 26, 2026 <sup>p. 28</sup>
=== AXA Investor Relations | Keep in touch ===
* '''
** Investor Relations +33 1 40 75 48 42 <sup>p. 29</sup>
** investor.relations@axa.com <sup>p. 29</sup>
* '''Follow us''': www.axa.com <sup>p. 29</sup>
* '''Upcoming events''': <sup>p. 29</sup>
** March: Roadshows in Europe and US <sup>p. 29</sup>
** May 5: 1Q25 Activity Indicators in Paris <sup>p. 29</sup>
Line 980 ⟶ 982:
** July 31: HY26 Earnings Release in Paris <sup>p. 29</sup>
** September 21: AXA Investor Day in London <sup>p. 29</sup>
== Appendices ==
Line 991 ⟶ 987:
* Appendices <sup>p. 30</sup>
* '''Debt and Invested Assets''' <sup>p. 31</sup>
* Additional P&C disclosures <sup>p. 36</sup>
* Additional IFRS17 disclosures <sup>p. 41</sup>
* Sustainability <sup>p. 44</sup>
=== Gross financial debt and maturity breakdown as of December 31st, 2025 ===
Line 1,000 ⟶ 996:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Gross financial debt by type
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" | Total
|-
| style="text-align:left" |
| style="text-align:right" | 3.5
| style="text-align:right" | 10.8
| style="text-align:right" | 4.8
| style="text-align:right" | 19.2
|-
| style="text-align:left" | FY25
| style="text-align:right" | 3.5
| style="text-align:right" | 12.2
| style="text-align:right" | 4.6
| style="text-align:right" | 22.3
|-
| style="text-align:left" | Jan 1st 2026
| style="text-align:right" | 5.8
| style="text-align:right" | 11.3
| style="text-align:right" | 3.2
| style="text-align:right" | 20.3
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Contractual maturity breakdown
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" | 0.5
| style="text-align:right" | 0.5
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2026
| style="text-align:right" | 0.9
| style="text-align:right" | 0.9
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2027
| style="text-align:right" | 0.5
| style="text-align:right" | 0.5
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2028
| style="text-align:right" | 0.9
| style="text-align:right" | 0.9
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2029
| style="text-align:right" | 0.9
| style="text-align:right" | 0.9
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2030
| style="text-align:right" | 0.9
| style="text-align:right" | 0.9
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2031-2039
| style="text-align:right" | 0.9
| style="text-align:right" | 0.9
| style="text-align:right" | 0.5
|-
| style="text-align:left" | ≥2040
| style="text-align:right" | 10.8
| style="text-align:right" | 0.2
| style="text-align:right" | 1.4
|-
| style="text-align:left" | Undated
| style="text-align:right" | 4.6
| style="text-align:right" | 0.7
| style="text-align:right" | 0.5
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Grandfathered debt
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" | 0.7
| style="text-align:right" | 0.2
|-
| style="text-align:left" |
| style="text-align:right" | 0.2
| style="text-align:right" | —
|-
| style="text-align:left" | Undated
| style="text-align:right" | 0.5
| style="text-align:right" | —
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Economic maturity breakdown
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" | 0.1
| style="text-align:right" | 0.1
| style="text-align:right" | 0.1
|-
| style="text-align:left" |
| style="text-align:right" | 0.1
| style="text-align:right" | 0.1
| style="text-align:right" | 0.1
|-
| style="text-align:left" | 2027
| style="text-align:right" | 2.4
| style="text-align:right" | 0.1
| style="text-align:right" | 0.1
|-
| style="text-align:
| style="text-align:right" | 2.0
| style="text-align:right" | 0.1
| style="text-align:right" | 0.1
|-
| style="text-align:left" |
| style="text-align:right" | 0.9
| style="text-align:right" | 0.1
| style="text-align:right" | 0.1
|-
| style="text-align:left" | 2030
| style="text-align:right" | 0.7
| style="text-align:right" | 0.1
| style="text-align:right" | 0.1
|-
| style="text-align:left" | 2031-2039
| style="text-align:right" | 6.4
| style="text-align:right" | 0.2
| style="text-align:right" | 1.5
|-
| style="text-align:left" | ≥2040
| style="text-align:right" | 0.5
| style="text-align:right" | 0.1
| style="text-align:right" | 0.7
|-
| style="text-align:left" | Undated
| style="text-align:right" | 4.0
| style="text-align:right" | 0.1
| style="text-align:right" | 0.7
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Grandfathered debt
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" | 0.7
| style="text-align:right" | 0.2
|-
| style="text-align:left" |
| style="text-align:right" | 0.2
| style="text-align:right" | —
|-
| style="text-align:left" | Undated
| style="text-align:right" | 0.8
| style="text-align:right" | —
|}
</div>
* Debt gearing: FY24 20.6%; FY25 22.3% <sup>p. 32</sup>
* Economic maturity takes into account the first date of step up calls on institutionally placed subordinated debt <sup>p. 32</sup>
* For Solvency 2 RT1 debt, the undated nature of the instrument is retained for this diagram, as it has no step-up <sup>p. 32</sup>
* '''Jan 1st 2026''' (End of the grandfathering period): Total
=== General Account invested assets ===
Line 1,174 ⟶ 1,186:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 Total General Account invested assets
! style="text-align:left" |
! class="col-s" style="text-align:right" | Share
|-
Line 1,210 ⟶ 1,193:
| style="text-align:right" | 345
| style="text-align:right" | 77%
|-
| style="text-align:left" | Real estate
Line 1,247 ⟶ 1,218:
| style="text-align:right" | 0%
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
|}
</div>
* Duration gap: -0.4 year <sup>p. 33</sup>
* o/w Corporate bonds and loans: 121 (27%) <sup>p. 33</sup>
** Other fixed income includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn) and Agency Pools (EUR 8bn) <sup>p. 33</sup>
* Listed equities includes hedges; listed equities excluding hedges at EUR 14bn <sup>p. 33</sup>
* Private equity and hedge funds includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn) and Non-listed Equities (EUR 1bn) <sup>p. 33</sup>
* Refer to the financial supplement for more details <sup>p. 33</sup>
=== Structured and Private Credit assets ===
Line 1,262 ⟶ 1,237:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Invested assets by structured and private credit type, FY25 <sup>p. 34</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | Residential Mortgages
Line 1,291 ⟶ 1,265:
| style="text-align:right" | 0%
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
|}
</div>
* EUR 6bn Dutch mortgages, NHG guaranteed <sup>p. 34</sup>
* EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV) <sup>p. 34</sup>
* 91% senior CLOs with circa 40% subordination (100% rated AAA-A and
* Skewed towards resilient industries (Telecom, Utilities, Transport) <sup>p. 34</sup>
* Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV <sup>p. 34</sup>
* Strong diversification with EUR 8m average ticket <sup>p. 34</sup>
* Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation <sup>p. 34</sup>
* o/w 54% participating <sup>p. 34</sup>
* G/A: General Account <sup>p. 34</sup>
=== Investment portfolio | Fixed Income reinvestment ===
Line 1,309 ⟶ 1,285:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 Fixed Income Reinvestment
! style="text-align:left" |
! class="col-s" style="text-align:right" | Share
! class="col-s" style="text-align:right" | Average rating
! class="col-s" style="text-align:right" | Yield
|-
| style="text-align:left" | Government bonds & related
| style="text-align:right" | 32%
| style="text-align:right" | AA
| style="text-align:right" | 3.5%
|-
| style="text-align:left" | Investment grade credit
| style="text-align:right" | 40%
| style="text-align:right" | A
| style="text-align:right" | —
|-
| style="text-align:left" | ABS/CLO/IG fund financing
| style="text-align:right" | 21%
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Below investment grade credit
| style="text-align:right" | 7%
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Public fixed income
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 3.5%
|-
| style="text-align:left" | Private & Structured fixed income
| style="text-align:right" |
| style="text-align:right" | —
| style="text-align:right" | 4.7%
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|}
</div>
* EUR 57 billion fixed income invested at 3.9% <sup>p. 35</sup>
** Average duration of 9 years <sup>p. 35</sup>
** Includes EUR 19.7 billion of Private & Structured Credit invested at 4.7% (CLOs, ABS, Infra & CRE debt, Fund financing and Private HY) <sup>p. 35</sup>
** Gradual shift from alternative total return assets to Private & Structured credit <sup>p. 35</sup>
* Government and Corporate bonds and related <sup>p. 35</sup>
* Private & Structured credit (CLOs, ABS, Infra & CRE debt, Fund financing and Private hybrid) <sup>p. 35</sup>
* '''Table of contents''':
Line 1,363 ⟶ 1,345:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 GWP by line of business and geography, USD 19bn total <sup>p. 37</sup>
! style="text-align:left" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | Casualty
Line 1,395 ⟶ 1,377:
| style="text-align:right" | —
| style="text-align:right" | 19%
|}
</div>
* Well diversified across lines of business and geographies <sup>p. 37</sup>
* Leading market positions across lines <sup>p. 37</sup>
** Top 3 globally <sup>p. 37</sup>
** Marine <sup>p. 37</sup>
* Managing the cycle to deliver consistent profitability <sup>p. 37</sup>
** (scatter plot) '''Profitability vs. Ex-price growth (%)''':
*** Property (
*** Specialty (
*** Casualty (
*** Professional lines (
=== P&C | Focus on Reserves ===
Line 1,418 ⟶ 1,396:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Claims and technical reserves ratios,
! style="text-align:left" | %
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" | 179%
| style="text-align:right" | —
| style="text-align:right" | 213%
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" | 185%
| style="text-align:right" | —
| style="text-align:right" | 227%
| style="text-align:right" | —
|-
| style="text-align:left" | FY20
| style="text-align:right" | 193%
| style="text-align:right" | —
| style="text-align:right" | 233%
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" | —
| style="text-align:right" | 226%
| style="text-align:right" | —
|-
| style="text-align:left" | FY22
| style="text-align:right" | 189%
| style="text-align:right" | 198%
| style="text-align:right" | 227%
| style="text-align:right" | 234%
|-
| style="text-align:left" | FY23
| style="text-align:right" | —
| style="text-align:right" | 195%
| style="text-align:right" | —
| style="text-align:right" | 232%
|-
| style="text-align:left" |
| style="text-align:right" | —
| style="text-align:right" | 180%
| style="text-align:right" | —
| style="text-align:right" | 216%
|-
| style="text-align:left" | FY25
| style="text-align:right" | —
| style="text-align:right" | 175%
| style="text-align:right" | —
| style="text-align:right" |
|}
</div>
* '''Claims reserves ratio''' (Net undiscounted claims reserves/Net earned premiums) <sup>p. 38</sup>
* '''Technical reserves ratio''' (Net undiscounted technical reserves /Net earned premiums) <sup>p. 38</sup>
Line 1,479 ⟶ 1,459:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Insurance segment occurrence protection,
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Capacity
Line 1,486 ⟶ 1,466:
| style="text-align:left" | EU Windstorm
| style="text-align:right" | 4.0
| style="text-align:right" |
|-
| style="text-align:left" | Europe Flood
| style="text-align:right" | 2.1
| style="text-align:right" |
|-
| style="text-align:left" | Europe Earthquake
| style="text-align:right" | 2.1
| style="text-align:right" |
|-
| style="text-align:left" | NA Hurricane
| style="text-align:right" | 1.2
| style="text-align:right" |
|-
| style="text-align:left" | NA Earthquake
| style="text-align:right" | 1.2
| style="text-align:right" |
|-
| style="text-align:left" | Per other perils
| style="text-align:right" |
| style="text-align:right" |
|}
</div>
* Stable retention levels maintained in 2026 as in 2025
* (diagram) '''Reinsurance segment (illustrative)''': Alternative Capital & Cat Bonds
* Footnote 1: Excludes local reinsurance covers
* Footnote 2: Varying retention between MX and NA (EUR 400m MX, EUR 600m NA)
* Footnote 3: Other perils include Turkey earthquake, Other Europe and NA perils, South America Earthquake as well as a series of other secondary perils
=== P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026 ===
<div style="overflow-x:auto">
{| class="wikitable
|+ Group underlying earnings deviation to average Nat Cat charges
! style="text-align:left" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | 1/20y (95th percentile)
| class="col-s" style="text-align:right" | -EUR 1.
|-
| style="text-align:left" | 1/10y (90th percentile)
| class="col-s" style="text-align:right" | -EUR 0.
|-
| style="text-align:left" | 1/5y (80th percentile)
| class="col-s" style="text-align:right" | -EUR 0.
|-
| style="text-align:left" | Median (50th percentile)
| class="col-s" style="text-align:right" | EUR 0.
|-
| style="text-align:left" | 1/5y (20th percentile)
| class="col-s" style="text-align:right" | EUR 0.
|-
| style="text-align:left" | 1/10y (10th percentile)
| class="col-s" style="text-align:right" | EUR 0.
|-
| style="text-align:left" | 1/20y (5th percentile)
| class="col-s" style="text-align:right" | EUR 0.
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Average Expected Nat Cat charges net of reinsurance, pre-tax <sup>p. 40</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | 2025
! class="col-s" style="text-align:right" | 2026
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" | 2.
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
|}
</div>
* Footnote 1: Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance).
* (bar) '''
* (bar) '''Less severe years (Positive deviation in ca. 60% of cases)''':
*
**
**
**
** 4. Sustainability <sup>p. 44</sup>
=== P&C | Margin analysis ===
Line 1,580 ⟶ 1,558:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ P&C Underlying Earnings walk,
! style="text-align:left" | EUR million unless otherwise mentioned
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" | Change
|-
Line 1,632 ⟶ 1,610:
| style="text-align:right" | -1.1%
| style="text-align:right" | +0.7pt
|-
| style="text-align:left" | '''Financial Result'''
Line 1,675 ⟶ 1,645:
| style="text-align:left" | 2025 Insurance Finance Expenses (pre-tax)
| style="text-align:right" | ~-1.4bn
| style="text-align:right" | —
|-
Line 1,700 ⟶ 1,662:
| style="text-align:right" | 5,872
| style="text-align:right" | +501
|-
| style="text-align:left" | Growth vs. FY24 (at constant FX)
| style="text-align:right" | +9%
| style="text-align:right" | —
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Impact
|-
| style="text-align:left" | +25bps
| style="text-align:right" | +0.2
|-
| style="text-align:left" | -25bps
| style="text-align:right" | -0.2
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable"
|+ Sensitivity of 2025e Insurance Finance Expenses to changes in 2025 current AY Discount <sup>p. 42</sup>
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" | Impact
|-
| style="text-align:left" | +25bps
| class="col-s" style="text-align:right" | ~-50
|-
| style="text-align:left" | -25bps
| class="col-s" style="text-align:right" | ~+50
|}
</div>
* Changes versus FY24 at constant FX <sup>p. 42</sup>
* Reinvestment yield on fixed income assets <sup>p. 42</sup>
* Parallel shift of the full-year average yield curve (average of monthly opening discount rates of 2025) used for discounting FY25 current accident year net reserve <sup>p. 42</sup>
* (flow) '''Technical Result''' (In Euro million, pre-tax) <sup>p. 42</sup>
* (flow) '''Financial Result''' (In Euro million, pre-tax) <sup>p. 42</sup>
* (flow) '''Underlying Earnings before tax''' <sup>p. 42</sup>
=== L&H | Margin analysis ===
Line 1,711 ⟶ 1,708:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ L&H Underlying Earnings walk,
! style="text-align:left" | EUR million unless otherwise mentioned
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" | Change
|-
Line 1,791 ⟶ 1,788:
| style="text-align:right" | 3,501
| style="text-align:right" | +219
|-
| style="text-align:left" | Growth vs. FY24 (at constant FX)
| style="text-align:right" | +7%
| style="text-align:right" | —
|}
</div>
<div style="overflow-x:auto">
Line 1,834 ⟶ 1,832:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Invested assets
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Value
! class="col-s" style="text-align:right" | % of total G/A portfolio
|-
Line 1,862 ⟶ 1,861:
| style="text-align:right" | 0%
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
|}
</div>
* Includes scope impact <sup>p. 43</sup>
* Changes versus FY24 at constant FX <sup>p. 43</sup>
* Reinvestment yield on fixed income assets <sup>p. 43</sup>
* Incl. recapture of Laya <sup>p. 43</sup>
* EUR 6bn Dutch mortgages, NHG guaranteed <sup>p. 43</sup>
* EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV) <sup>p. 43</sup>
* 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA) <sup>p. 43</sup>
* Skewed towards resilient industries (Telecom, Utilities, Transport) <sup>p. 43</sup>
* Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV <sup>p. 43</sup>
*
* Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation <sup>p. 43</sup>
* o/w 54% participating <sup>p. 43</sup>
* (flow) '''Technical Result''' (In Euro million, pre-tax) <sup>p. 43</sup>
* (flow) '''Financial Result''' (In Euro million, pre-tax) <sup>p. 43</sup>
* (flow) '''Underlying Earnings before tax''' <sup>p. 43</sup>
* '''Table of contents''' <sup>p. 44</sup>
** 1. Debt and Invested Assets <sup>p. 31</sup>
** 2. Additional P&C disclosures <sup>p. 36</sup>
** 3. Additional IFRS17 disclosures <sup>p. 41</sup>
** 4. Sustainability <sup>p. 44</sup>
=== Expanding AXA's role in society: AXA for Progress Index 1 ===
Line 1,883 ⟶ 1,893:
<div style="overflow-x:auto">
{| class="wikitable"
|+ AXA's Sustainability
! style="text-align:left" |
! class="col-m" style="text-align:right" | Target
! class="col-m" style="text-align:right" | 2025 Result
|-
| style="text-align:left" | '''As a Global INVESTOR'''
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" | —
|-
| style="text-align:left" | Climate transition financing
| class="col-m" style="text-align:right" | EUR 5bn per year
| class="col-m" style="text-align:right" | EUR 6.4bn
|-
| style="text-align:left" |
| class="col-m" style="text-align:right" | EUR 500m
| class="col-m" style="text-align:right" | EUR 1.4bn
|-
| style="text-align:left" | '''As a Global INSURER'''
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" | —
|-
| style="text-align:left" | P&C GWP to support transition underwriting (cumulative 2024-2026)
| class="col-m" style="text-align:right" | EUR 6bn
| class="col-m" style="text-align:right" | EUR 4.6bn
|-
| style="text-align:left" |
| class="col-m" style="text-align:right" | >20,000
| class="col-m" style="text-align:right" | 19,698 Cumulative 2024-2025
|-
| style="text-align:left" |
| class="col-m" style="text-align:right" | >20m
| class="col-m" style="text-align:right" | 20.6m
|-
| style="text-align:left" | '''As a COMPANY'''
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" | —
|-
| style="text-align:left" | AXA Group employees trained on climate adaptation by 2026
| class="col-m" style="text-align:right" | >80,000
| class="col-m" style="text-align:right" | 46,420
|-
| style="text-align:left" |
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" | -64% Reduction against 2019
|-
| style="text-align:left" |
| class="col-m" style="text-align:right" | 50%
| class="col-m" style="text-align:right" | 56%
|}
</div>
* AXA's Sustainability Statement is subject to completion of a certification with limited assurance by AXA Group's auditors and will be presented to the AXA Board of Directors for approval on March 11, 2026 <sup>p. 45</sup>
* Scope: Corporate and sovereign debt, real estate and private assets. Timeframe: per annum through 2026 <sup>p. 45</sup>
* Scope: AXA France, AXA Germany, AXA Switzerland, AXA XL, AXA Hong Kong, AXA Japan, AXA Mexico, and AXA XL. Gross Written Premiums (GWP). Timeframe: cumulative 2024-2026 <sup>p. 45</sup>
* Scope: Commercial lines portfolio of AXA France, AXA Germany, AXA Switzerland, AXA UK, AXA Belgium, AXA Hong Kong, AXA Mexico, and AXA XL. Climate solutions & services include: (i) training/education, (ii) risk assessment/awareness, (iii) gap analysis, (iv) prevention/adaptation solution, and/or (v) crisis management/remediation response. Timeframe: cumulative 2024-2026. Following strong support within the Group for climate adaptation solutions & services in 2024 and 2025, AXA is proposing a significant increase in the target for the 2024-2026 period, from >9,000 to >20,000 <sup>p. 45</sup>
* Inclusive insurance includes underserved populations and markets and modest income segments in mature markets <sup>p. 45</sup>
* Number of employees who have been trained on climate change adaptation, completing a training under the AXA Sustainability Academy. Timeframe: cumulative 2024-2026 <sup>p. 45</sup>
* Variation of AXA Group absolute carbon emissions (scope: energy Scopes 1 and 2, car fleet and business travel). Timeframe: 2019-2030 <sup>p. 45</sup>
* Carbon credits from projects that focus on capturing and storing carbon emissions from the atmosphere using nature-based or technical solutions (e.g. restorative agriculture, forest restoration or carbon capture and storage) <sup>p. 45</sup>
* Target revised in 2025 <sup>p. 45</sup>
=== Sustainability Performance & Ratings ===
Line 1,929 ⟶ 1,958:
<div style="overflow-x:auto">
{| class="wikitable"
|+ ESG
! style="text-align:left" | Rating
! class="col-m" style="text-align:right" |
! class="col-m" style="text-align:right" | 2025 Result
|-
| style="text-align:left" | S&P Global
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" | 97th
|-
| style="text-align:left" | S&P Global
| class="col-m" style="text-align:right" | Score
| class="col-m" style="text-align:right" | AAA
|-
| style="text-align:left" | MSCI
| class="col-m" style="text-align:right" | Score
| class="col-m" style="text-align:right" | AAA
|-
| style="text-align:left" | CDP
| class="col-m" style="text-align:right" | Score
| class="col-m" style="text-align:right" | B
|-
| style="text-align:left" | Morningstar Sustainalytics
| class="col-m" style="text-align:right" | ESG Risk Rating
| class="col-m" style="text-align:right" | 17.0 - Low risk
|-
| style="text-align:left" | FTSE Russell
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" | 4.3/5
|}
</div>
* The CSA ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (more precisely AXA Restricted Shares) <sup>p. 46</sup>.
* Results as of February 6th, 2026 <sup>p. 46</sup>.
Line 1,964 ⟶ 2,001:
** China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S and India (Life activities disposed on March 11, 2024 and holding) businesses which are consolidated under the equity method and contribute only to NBV, PVEP, the underlying earnings and net income <sup>p. 47</sup>.
** '''Africa''': Morocco (insurance activities and holding) and Nigeria (insurance activities and holding), Egypt (insurance activities and holding) which are fully consolidated <sup>p. 47</sup>.
** '''EME-LATAM''': Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding) and Türkiye (insurance activities and holding) which are fully consolidated as well as Russia (Reso) (insurance activities) which consolidated under the equity method and contributes only to the net income <sup>p. 47</sup>.
** AXA Mediterranean Holdings <sup>p. 47</sup>.
* '''Transversal & Other''': includes AXA Assistance, AXA Liabilities Managers, AXA and other Central Holdings <sup>p. 47</sup>.
* '''AXA Investment Managers (until July 1, 2025)''': includes AXA Investment Managers, Select (previously referred to as Architas) and Capza which are fully consolidated and Asian joint ventures which are consolidated under the equity method <sup>p. 47</sup>.
* Unless otherwise specified herein, all comparative figures for going back to 2023 are under the IFRS17/9 accounting standards that became effective on January 1, 2023 <sup>p. 47</sup>.
* Figures for financial periods prior to 2023 have not been restated under IFRS17/9 and are presented under IFRS4, the applicable accounting standard that preceded the implementation of IFRS17/9 <sup>p. 47</sup>.
Line 1,980 ⟶ 2,016:
* '''Financial result''': consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder's equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow <sup>p. 48</sup>.
* '''Gross Written Premiums and Other Revenues (GWP & Other Revenues)''': represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business) <sup>p. 48</sup>.
*
* '''New Business Value (NBV)''': the value of newly issued contracts during the current year <sup>p. 48</sup>. It consists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests <sup>p. 48</sup>.
* '''New Business Contractual Service Margin (NB CSM)''': a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided <sup>p. 48</sup>.
* '''New Business Value margin (NBV margin)''': ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP <sup>p. 48</sup>.
* '''Operating variance''': the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes <sup>p. 48</sup>. Operating variance is net of reinsurance <sup>p. 48</sup>.
* '''Present value of expected premiums (PVEP)''': the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term <sup>p. 48</sup>. PVEP is discounted at the reference interest rate and PVEP is Group share <sup>p. 48</sup>.
* '''Technical experience''': consists the impacts on the underlying earnings if (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses <sup>p. 48</sup>.
* '''Underlying return on in-force''': represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance <sup>p. 48</sup>.
Line 2,000 ⟶ 2,033:
== Abbreviations ==
* '''AA''':
* '''AAA''':
* '''ABS''': Asset-Backed Securities
* '''AEP''': Aggregate Exceedance Probability
* '''AI''': Artificial Intelligence
* '''AMF''': Autorité des
* '''APAC''': Asia-Pacific
* '''AXA IM''': AXA Investment Managers
* '''AXA UK''': AXA United Kingdom
* '''AXA XL''': AXA XL (AXA's corporate and specialty risk division)
* '''AY''': Accident Year
* '''BBA''':
* '''BNP''': Banque Nationale de Paris
* '''CDP''': Carbon Disclosure Project
Line 2,015 ⟶ 2,051:
* '''CSA''': Corporate Sustainability Assessment
* '''CSM''': Contractual Service Margin
* '''CY''':
* '''DPS''': Dividend Per Share
* '''EME''': Emerging Markets
Line 2,027 ⟶ 2,063:
* '''FX''': Foreign Exchange
* '''GAAP''': Generally Accepted Accounting Principles
* '''GEP''': Gross Earned
* '''GF
* '''GWP''': Gross Written Premiums
* '''HKD''': Hong Kong Dollar
Line 2,051 ⟶ 2,086:
* '''PVEP''': Present Value of Expected Profits
* '''PYD''': Prior Years' Reserve Development
* '''RCG''': Reinsurance Commission and
* '''ROE''': Return
* '''SCR''': Solvency Capital Requirement
* '''SHE''': Shareholders' Equity
* '''SME''': Small and Medium-sized Enterprises
* '''TVOG''': Time Value of Options
* '''UEPS''': Underlying Earnings Per Share
* '''UK''': United Kingdom
| |||